Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nalbantoglu

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Human Gene Therapy|April 29, 1998
High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppressionJ M Howell, H Lochmüller, A O'Hara, et al.
Human Gene Therapy|October 1, 1996
Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiencyB J Petrof, H Lochmüller, B Massie, et al.
Human Gene Therapy|April 11, 2000
Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular routeW K Cho, S Ebihara, J Nalbantoglu, et al.
Cell|April 6, 1990
Cellular isoform of the scrapie agent protein participates in lymphocyte activationN R Cashman, R Loertscher, J Nalbantoglu, et al.
Neurology|December 31, 1997
Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's diseaseM Melanson, J Nalbantoglu, S Berkovic, et al.
Neuroreport|July 7, 1997
The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transferH D Durham, M A Alonso-Vanegas, A F Sadikot, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1989
Ascertainment of informative Alzheimer disease families from the IMAGE Project registry for genetic linkage analysis studiesD Gautrin, J Nalbantoglu, G Lacoste-Royal, et al.
Neurology|October 16, 1999
Myophosphorylase gene transfer in McArdle's disease myoblasts in vitroG Pari, M M Crerar, J Nalbantoglu, et al.
Human Gene Therapy|September 19, 2001
Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene productsR Gilbert, J Nalbantoglu, J M Howell, et al.
Gene Therapy|August 1, 1996
Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) miceH Lochmüller, B J Petrof, G Pari, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Human Gene Therapy|April 29, 1998
High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppressionJ M Howell, H Lochmüller, A O'Hara, et al.
Human Gene Therapy|October 1, 1996
Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiencyB J Petrof, H Lochmüller, B Massie, et al.
Human Gene Therapy|April 11, 2000
Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular routeW K Cho, S Ebihara, J Nalbantoglu, et al.
Cell|April 6, 1990
Cellular isoform of the scrapie agent protein participates in lymphocyte activationN R Cashman, R Loertscher, J Nalbantoglu, et al.
Neurology|December 31, 1997
Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's diseaseM Melanson, J Nalbantoglu, S Berkovic, et al.
Neuroreport|July 7, 1997
The immunosuppressant FK506 prolongs transgene expression in brain following adenovirus-mediated gene transferH D Durham, M A Alonso-Vanegas, A F Sadikot, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1989
Ascertainment of informative Alzheimer disease families from the IMAGE Project registry for genetic linkage analysis studiesD Gautrin, J Nalbantoglu, G Lacoste-Royal, et al.
Neurology|October 16, 1999
Myophosphorylase gene transfer in McArdle's disease myoblasts in vitroG Pari, M M Crerar, J Nalbantoglu, et al.
Human Gene Therapy|September 19, 2001
Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene productsR Gilbert, J Nalbantoglu, J M Howell, et al.
Gene Therapy|August 1, 1996
Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) miceH Lochmüller, B J Petrof, G Pari, et al.
Pageof 8